These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25124022)
21. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229 [TBL] [Abstract][Full Text] [Related]
22. Imaging of late complications from mantle field radiation in lymphoma patients. Brennan S; Hann LE; Yahalom J; Oeffinger KC; Rademaker J Radiol Clin North Am; 2008 Mar; 46(2):419-30, x. PubMed ID: 18619388 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication? Vaduganathan M; Prasad V Eur J Heart Fail; 2016 Feb; 18(2):128-32. PubMed ID: 26663426 [No Abstract] [Full Text] [Related]
24. Optimizing cardio-oncology programs for cancer patients. Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828 [No Abstract] [Full Text] [Related]
31. Radiation-induced effects to nontarget abdominal and pelvic viscera. Peterson CM; Menias CO; Katz DS Radiol Clin North Am; 2014 Sep; 52(5):1041-53. PubMed ID: 25173657 [TBL] [Abstract][Full Text] [Related]
32. Predicting and preventing the cardiotoxicity of cancer therapy. Anderson B; Sawyer DB Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852 [TBL] [Abstract][Full Text] [Related]
33. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology. Khouri MG; Klein MR; Velazquez EJ; Jones LW Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive cardiovascular imaging in primary prevention: does it influence management and outcomes? Beller GA J Nucl Cardiol; 2011 May; 18(3):383-4. PubMed ID: 21491167 [No Abstract] [Full Text] [Related]
35. Should the 'echo guidelines' be followed in cancer patients? Herrmann J; Yang EH Future Oncol; 2015; 11(14):2021-5. PubMed ID: 26198830 [No Abstract] [Full Text] [Related]
36. State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review. Berardi R; Caramanti M; Savini A; Chiorrini S; Pierantoni C; Onofri A; Ballatore Z; De Lisa M; Mazzanti P; Cascinu S Crit Rev Oncol Hematol; 2013 Oct; 88(1):75-86. PubMed ID: 23522920 [TBL] [Abstract][Full Text] [Related]
37. Communications in cardiology: why digital? Vijayaraghavan G Indian Heart J; 2001; 53(2):231-4. PubMed ID: 11428486 [No Abstract] [Full Text] [Related]
38. [Cardiac disease in patients with tumors and tumor therapy]. Hoppe UC Med Klin (Munich); 2006 Mar; 101 Suppl 1():31-5. PubMed ID: 16802515 [TBL] [Abstract][Full Text] [Related]
39. The postradiation neck: evaluating response to treatment and recognizing complications. Glastonbury CM; Parker EE; Hoang JK AJR Am J Roentgenol; 2010 Aug; 195(2):W164-71. PubMed ID: 20651177 [TBL] [Abstract][Full Text] [Related]
40. Imaging the central nervous system effects of radiation and chemotherapy of pediatric tumors. Edwards-Brown MK; Jakacki RI Neuroimaging Clin N Am; 1999 Feb; 9(1):177-93. PubMed ID: 9974505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]